379 related articles for article (PubMed ID: 9246485)
21. Alzheimer's disease. Molecular consequences of presenilin-1 mutation.
Gandy S; Naslund J; Nordstedt C
Nature; 2001 Jun; 411(6838):654-6. PubMed ID: 11395757
[TBL] [Abstract][Full Text] [Related]
22. [Alzheimer's disease and genetic factors].
Leuba G; Savioz A
Rev Med Suisse Romande; 1997 Nov; 117(11):871-8. PubMed ID: 9471651
[No Abstract] [Full Text] [Related]
23. The Glu318Gly mutation of the presenilin-1 gene does not necessarily cause Alzheimer's disease.
Mattila KM; Forsell C; Pirttilä T; Rinne JO; Lehtimäki T; Röyttä M; Lilius L; Eerola A; St George-Hyslop PH; Frey H; Lannfelt L
Ann Neurol; 1998 Dec; 44(6):965-7. PubMed ID: 9851443
[TBL] [Abstract][Full Text] [Related]
24. [The complex enzymic process yielding beta-amyloid protein in Alzheimer's disease].
Sela B
Harefuah; 2000 Jul; 139(1-2):42-7. PubMed ID: 10979452
[No Abstract] [Full Text] [Related]
25. Molecular genetics of Alzheimer's disease.
Sorbi S; Nacmias B; Forleo P
Aging (Milano); 1998 Apr; 10(2):157. PubMed ID: 9666211
[No Abstract] [Full Text] [Related]
26. [Genes in Alzheimer's disease].
Hoenicka J
Rev Neurol; 2006 Mar 1-15; 42(5):302-5. PubMed ID: 16538594
[TBL] [Abstract][Full Text] [Related]
27. Alzheimer's disease. A technical KO of amyloid-beta peptide.
Haass C; Selkoe DJ
Nature; 1998 Jan; 391(6665):339-40. PubMed ID: 9450743
[No Abstract] [Full Text] [Related]
28. Apolipoprotein E genotype and alpha-tocopherol modulate amyloid precursor protein metabolism and cell cycle regulation.
Huebbe P; Schaffer S; Jofre-Monseny L; Boesch-Saadatmandi C; Minihane AM; Müller WE; Eckert GP; Rimbach G
Mol Nutr Food Res; 2007 Dec; 51(12):1510-7. PubMed ID: 18030662
[TBL] [Abstract][Full Text] [Related]
29. Behavioral phenotypes of amyloid-based genetically modified mouse models of Alzheimer's disease.
Kobayashi DT; Chen KS
Genes Brain Behav; 2005 Apr; 4(3):173-96. PubMed ID: 15810905
[TBL] [Abstract][Full Text] [Related]
30. [Molecular basics of Alzheimer's disease].
Grigorenko AP; Rogaev EI
Mol Biol (Mosk); 2007; 41(2):331-45. PubMed ID: 17514900
[TBL] [Abstract][Full Text] [Related]
31. [From gene to disease; presenilins and Alzheimer disease].
Roos RA; Cruts M
Ned Tijdschr Geneeskd; 2001 Oct; 145(42):2027-9. PubMed ID: 11695101
[TBL] [Abstract][Full Text] [Related]
32. A beta amyloidogenesis: unique, or variation on a systemic theme?
Kisilevsky R; Fraser PE
Crit Rev Biochem Mol Biol; 1997; 32(5):361-404. PubMed ID: 9383610
[TBL] [Abstract][Full Text] [Related]
33. [Genetics of late-onset Alzheimer's disease: vascular risk and beta-amyloid metabolism].
Panza F; Solfrizzi V; D'Introno A; Capurso C; Colacicco AM; Torres F; Altomare E; Capurso A
Recenti Prog Med; 2002 Sep; 93(9):489-97. PubMed ID: 12355988
[TBL] [Abstract][Full Text] [Related]
34. Genetic study of Sardinian patients with Alzheimer's disease.
Piscopo P; Manfredi A; Malvezzi-Campeggi L; Crestini A; Spadoni O; Cherchi R; Deiana E; Piras MR; Confaloni A
Neurosci Lett; 2006 May; 398(1-2):124-8. PubMed ID: 16423463
[TBL] [Abstract][Full Text] [Related]
35. Neuropathological characterization of mutant amyloid precursor protein yeast artificial chromosome transgenic mice.
Kulnane LS; Lamb BT
Neurobiol Dis; 2001 Dec; 8(6):982-92. PubMed ID: 11741394
[TBL] [Abstract][Full Text] [Related]
36. Endocytic disturbances distinguish among subtypes of Alzheimer's disease and related disorders.
Cataldo A; Rebeck GW; Ghetri B; Hulette C; Lippa C; Van Broeckhoven C; van Duijn C; Cras P; Bogdanovic N; Bird T; Peterhoff C; Nixon R
Ann Neurol; 2001 Nov; 50(5):661-5. PubMed ID: 11706973
[TBL] [Abstract][Full Text] [Related]
37. Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity.
Wolfe MS; Xia W; Ostaszewski BL; Diehl TS; Kimberly WT; Selkoe DJ
Nature; 1999 Apr; 398(6727):513-7. PubMed ID: 10206644
[TBL] [Abstract][Full Text] [Related]
38. [Familial Alzheimer's disease by beta-amyloid protein precursor (beta APP) mutations].
Okochi M; Takeda M
Nihon Rinsho; 2004 Jan; 62 Suppl():86-9. PubMed ID: 15011326
[No Abstract] [Full Text] [Related]
39. [Alzheimer's disease: focus on beta-amyloid and gamma-secretase].
Iwatsubo T
Tanpakushitsu Kakusan Koso; 2004 May; 49(7 Suppl):1086-90. PubMed ID: 15168534
[No Abstract] [Full Text] [Related]
40. Familial Alzheimer's disease: site of mutation influences clinical phenotype.
Lippa CF; Swearer JM; Kane KJ; Nochlin D; Bird TD; Ghetti B; Nee LE; St George-Hyslop P; Pollen DA; Drachman DA
Ann Neurol; 2000 Sep; 48(3):376-9. PubMed ID: 10976645
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
